IL137965A - Method for producing spherical pellets with a polymeric coating - Google Patents

Method for producing spherical pellets with a polymeric coating

Info

Publication number
IL137965A
IL137965A IL13796599A IL13796599A IL137965A IL 137965 A IL137965 A IL 137965A IL 13796599 A IL13796599 A IL 13796599A IL 13796599 A IL13796599 A IL 13796599A IL 137965 A IL137965 A IL 137965A
Authority
IL
Israel
Prior art keywords
grains
encased
polymer dispersion
prostane
polymeric coating
Prior art date
Application number
IL13796599A
Other languages
English (en)
Other versions
IL137965A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL137965A0 publication Critical patent/IL137965A0/xx
Publication of IL137965A publication Critical patent/IL137965A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13796599A 1998-02-24 1999-02-24 Method for producing spherical pellets with a polymeric coating IL137965A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19808634A DE19808634A1 (de) 1998-02-24 1998-02-24 Mantel für eine pharmazeutische Zusammensetzung
PCT/EP1999/001100 WO1999043303A1 (fr) 1998-02-24 1999-02-24 Procede de preparation de grains granulaires spheriques enrobes

Publications (2)

Publication Number Publication Date
IL137965A0 IL137965A0 (en) 2001-10-31
IL137965A true IL137965A (en) 2005-11-20

Family

ID=7859315

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13796599A IL137965A (en) 1998-02-24 1999-02-24 Method for producing spherical pellets with a polymeric coating

Country Status (18)

Country Link
US (1) US6723372B1 (fr)
EP (1) EP1058542B1 (fr)
JP (1) JP2002504506A (fr)
KR (1) KR100623542B1 (fr)
AT (1) ATE303133T1 (fr)
AU (1) AU753261B2 (fr)
CA (1) CA2321969C (fr)
CZ (1) CZ299252B6 (fr)
DE (2) DE19808634A1 (fr)
DK (1) DK1058542T3 (fr)
ES (1) ES2247786T3 (fr)
HU (1) HU226066B1 (fr)
IL (1) IL137965A (fr)
NO (1) NO20004225L (fr)
PL (1) PL193071B1 (fr)
RU (1) RU2209060C2 (fr)
SK (1) SK284062B6 (fr)
WO (1) WO1999043303A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19828881A1 (de) * 1998-06-22 1999-12-23 Schering Ag Oxidationsinhibitor bei Prostan-Derivaten
US8323692B2 (en) * 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
ATE341312T1 (de) 2003-05-20 2006-10-15 Ethypharm Sa Orale pharmazeutische zusammensetzung mit verzögerter freisetzung
US8318230B2 (en) * 2005-05-02 2012-11-27 Henkel Ag & Co. Kgaa Use of debranched starch in extrusion-spheronization pharmaceutical pellets
EP1956013B1 (fr) 2005-11-30 2016-04-13 Fujifilm RI Pharma Co., Ltd. Diagnostic et remede pour une maladie provoquee par l'aggregation et/ou le depot d'amyloide
RU2702690C2 (ru) * 2015-08-13 2019-10-09 БИОЛИНГУС АйПи ЛЛСи Способ получения продуктов, содержащих стабилизированные активные вещества, и композиций, содержащих таковые
CN106822013B (zh) * 2015-11-30 2020-05-12 北京泰德制药股份有限公司 前列环素类似物缓释制剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA935093A (en) * 1969-07-28 1973-10-09 Eurand S.R.L. Method of preparing granules with controlled release of the active substance contained therein
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
DE3622487A1 (de) * 1986-07-02 1988-01-14 Schering Ag Arzneimittel mit verzoegerter wirkstoffabgabe
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
US5286493A (en) * 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
JP3277342B2 (ja) * 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
DE4236025A1 (de) * 1992-10-24 1994-04-28 Merck Patent Gmbh Orale Arzneiformen
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
RU2117475C1 (ru) * 1995-11-02 1998-08-20 Химико-фармацевтическое акционерное общество открытого типа "Октябрь" Водная акриловая дисперсия для производства энтеральных лекарственных форм
JPH10139659A (ja) * 1996-09-10 1998-05-26 Freunt Ind Co Ltd 球形粒子群、その製造方法及びそれを用いた球形粒子製剤

Also Published As

Publication number Publication date
WO1999043303A1 (fr) 1999-09-02
NO20004225D0 (no) 2000-08-23
PL342315A1 (en) 2001-06-04
DK1058542T3 (da) 2006-01-02
US6723372B1 (en) 2004-04-20
ATE303133T1 (de) 2005-09-15
KR100623542B1 (ko) 2006-09-13
HUP0100752A2 (hu) 2001-08-28
SK284062B6 (sk) 2004-09-08
CA2321969C (fr) 2007-04-10
ES2247786T3 (es) 2006-03-01
SK12422000A3 (sk) 2001-04-09
PL193071B1 (pl) 2007-01-31
EP1058542A1 (fr) 2000-12-13
NO20004225L (no) 2000-09-28
IL137965A0 (en) 2001-10-31
DE19808634A1 (de) 1999-08-26
KR20010041210A (ko) 2001-05-15
HU226066B1 (en) 2008-04-28
AU2835299A (en) 1999-09-15
AU753261B2 (en) 2002-10-10
JP2002504506A (ja) 2002-02-12
CZ299252B6 (cs) 2008-05-28
CZ20003088A3 (cs) 2000-11-15
CA2321969A1 (fr) 1999-09-02
RU2209060C2 (ru) 2003-07-27
EP1058542B1 (fr) 2005-08-31
DE59912501D1 (de) 2005-10-06

Similar Documents

Publication Publication Date Title
DE69829655T3 (de) Biofunktionelle polymere im überkritischem fluid hergestellt
CA2228610A1 (fr) Produits a liberation controlee
WO2002053599A3 (fr) Esters de cellulose oxydee biodegradable
EP0761213A3 (fr) Procédé pour la fabrication d'une préparation à libération retardée
WO1995024929A3 (fr) Systeme de liberation de genes polymeres
CA2514446A1 (fr) Composition comprenant un melange de principes actifs et methode pour la preparer
JPH06292825A (ja) 安定化された粉末状活性成分、それらを含む組成物、それらを得る方法及びそれらの適用
CA2127352A1 (fr) Preparation pharmaceutique sous la forme d'un comprime effervescent et/ou se desintegrant ou de granules a dissolution instantanee et procede d'obtention
CA2331785A1 (fr) Procede de preparation de microgel
IL137965A0 (en) Method for producing spherical pellets with a polymeric coating
NZ335364A (en) Pellets having a core 250-355 um coated with an antifungal and a polymer, pharmaceutical, and process
AU2001277570A1 (en) Oral pharmaceutical composition with controlled release and prolonged absorption
ES2148300T3 (es) Microcapsulas para la liberacion controlada de acido acetilsalicilico.
WO1990007859A3 (fr) Procede de regulation de liberation de sucralose dans une gomme a macher et gomme ainsi produite
AU8142594A (en) Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
EP0979648A3 (fr) Microsphères d'esters d'acide hyaluronique pour la libération contrôlée d'actifs
WO1996011675A3 (fr) Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
CA2120618A1 (fr) Installation et procede d'enrobage de particules
DE69929439D1 (de) Polyakrylsäure-granulate mit gesteuerter freigabe und verfahren zu dessen herstellung
DE59305700D1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
HK137693A (en) Granules of thiamine salt and the production thereof
CA2194610A1 (fr) Formulation a liberation prolongee d'hormone de croissance animale et procede de preparation de cette derniere
DE3884214D1 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
DE3880919D1 (de) Stabilisierter futtermittelzusatz und verfahren zu seiner herstellung.
CA2210125A1 (fr) Procede pour l'obtention d'articles moules par compression d'un materiau de type lignocellulose

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees